Small cell lung carcinomas express shared and private tumor antigens presented by HLA-A1 or HLA-A2

Cancer Research

Volumn 59, Issue 18, 1999, Pages 4642-4650

  Yamazaki, Koichi ^a   Spruill, Gina ^a   Rhoderick, Joseph ^a   Spielman, Julie ^a   Savaraj, Niramol ^a   Podack, Eckhard R ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; HLA A1 ANTIGEN; HLA A2 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; TUMOR ANTIGEN;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CANCER CELL CULTURE; CANCER CELL DESTRUCTION; CANCER IMMUNOTHERAPY; CELL MEDIATED CYTOTOXICITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DNA TRANSFECTION; HUMAN; HUMAN CELL; LUNG SMALL CELL CANCER; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

EID: 0033568150     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Van Waes, C., Monach, P. A., Urban, J. L., Wortzel, R. D., and Schreiber, H. Immunodominance deters the response to other tumor antigens thereby favoring escape: prevention by vaccination with tumor variants selected with cloned cytolytic T cells in vitro. Tissue Antigens, 47: 399-407, 1996.
2. Seung, L. P., Seung, S. K., and Schreiber, H. Antigenic cancer cells that escape immune destruction are stimulated by host cells. Cancer Res., 55: 5094-5100, 1995.
3. Samuels, V., Barrett, J. M., Bockman, S., Pantazis, C. G., and Allen, M. B., Jr. Immunocytochemical study of transforming growth factor expression in benign and malignant gliomas. Am. J. Pathol., 134: 894-902, 1989.
4. Huettner, C., Paulus, W., and Roggendorf, W. Messenger RNA expression of the immunosuppressive cytokine IL-10 in human gliomas. Am. J. Pathol., 146: 317-322, 1995.
5. Hahne, M., Rimoldi, D., Schroter, M., Romero, P., Schreier, M., French, L. E., Schneider, P., Bornand, T., Fontana, A., Lienard, D., Cerottini, J., and Tschopp, J. Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape. Science (Washington DC), 274: 1363-1366, 1996.
6. Wiley, S. R., Schooley, K., Smolak, P. J., Din, W. S., Huang, C. P., Nicholl, J. K., Sutherland, G. R., Smith, T. D., Rauch, C., Smith, C. A. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity, 3: 673-682, 1995.
7. Chicheportiche, Y., Bourdon, P. R., Xu, H., Hsu, Y. M., Scott, H., Hession, C., Garcia, I., and Browning, J. L. TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. J. Biol. Chem., 272: 32401-32410, 1997.
8. Browning, M. J., Krausa, P., Rowan, A., Bicknell, B. C., Bodmer, J. G., and Bodmer, W. F. Tissue typing the HLA-A locus from genomic DNA by sequence-specific PCR: comparison of HLA genotype and surface expression on colorectal tumor cell lines. Proc. Natl. Acad. Sci. USA, 90: 2842-2845, 1993.
9. Kaklamanis, L., Leek, R., Koukourakis, M., Gaiter, K. C., and Harris, A. L. Loss of transporter in antigen processing 1 transport protein and major histocompatibility complex class I molecules in metastatic versus primary breast cancer. Cancer Res., 55: 5191-5194, 1995.
10. Sanda, M. G., Restifo, N. P., Walsh, J. C., Kawakami, Y., Nelson, W. G., Pardoll, D. M., and Simons, J. W. Molecular characterization of defective antigen processing in human prostate cancer. J. Natl Cancer Inst., 87: 280-285, 1995.
11. Restifo, N. P., Esquivel, F., Kawakami, Y., Yewdell, J. W., Mule, J. J., Rosenberg, S. A., and Bennink, J. R. Identification of human cancers deficient in antigen processing. J. Exp. Med., 177: 265-272, 1993.
12. Chen, L., Ashe, S., Brady, W. A., Hellstrom, J., Hellstrom, K. E., Ledbetter, J. A., McGowan, P., and Linsley, P. S. Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell, 71: 1093-1102, 1992.
13. + T cells by B7-transfected melanoma cells. Science (Washington DC), 259: 368-370, 1993.
14. Yang, S., Darrow, T. L., and Seigler, H. F. Generation of primary tumor-specific cytotoxic T lymphocytes from autologous and human lymphocyte antigen class 1-matched allogeneic peripheral blood lymphocytes by B7 gene-modified melanoma cells. Cancer Res., 57: 1561-1568, 1997.
15. Imro, M. A., Dellabona, P., Manici, S., Heltai, S., Consogno, G., Bellone, M., Rugarli, C., and Protti, M. P. Human melanoma cells transfected with the B7-2 co-stimulatory molecule induce tumor-specific CD8+ cytotoxic T lymphocytes in vitro. Hum. Gene Ther., 9: 1335-1344, 1998.
16. van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaen, E., Van den Eynde, B., Knuth, A., and Boon, T. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science (Washington DC), 254: 1643-1647, 1991.
17. Brichard, V., Van Pel, A., Wolfel, T., Wolfel, C., De Plaen, E., Lethe, B., Coulie, P., and Boon, T. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med., 178: 489-495, 1993.
18. Gaugler, B., Van den Eynde, B., van der Bruggen, P., Romero, P., Gaforio, J. J., De Plaen, E., Lethe, B., Brasseur, F., and Boon, T. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J. Exp. Med., 179: 921-930, 1994.
19. Bakker, A. B. H., Schreurs, M. W. J., de Boer, A. J., Kawakami, Y., Rosenberg, S. A., Adema, G. J., and Figdor, C. G. Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes. J. Exp. Med., 179: 1005-1009, 1994.
20. Kawakami, Y., Eliyahu, S., Delgado, C. H., Robbins, P. F., Rivoltini, L., Topalian, S. L., Miki, T., and Rosenberg, S. A. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc. Natl. Acad. Sci. USA, 91: 3515-3519, 1994.
21. Van den Eynde, B., Peeters, O., De Backer, O., Gaugler, B., Lucas, S., and Boon, T. A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma. J. Exp. Med., 182: 689-698, 1995.
22. Boel, P., Wildmann, C., Sensi, M. L., Brasseur, R., Renauld, J-C., Coulie, P., Boon, T., and van der Bruggen, P. BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity, 2: 167-175, 1995.
23. Shichijo, S., Nakao, M., Imai, Y., Takasu, H., Kawamoto, M., Niiya, F., Yang, D., Toh, Y., Yamana, H., and Ito, K. A gene encoding anligenic peptides of human squamous cell carcinoma recognized by cytotoxic T lymphocytes. J. Exp. Med., 187: 277-288, 1998.
24. Slingluff, C. L., Jr., Cox, A. L., Stover, J. M., Jr., Moore, M. M., Hunt, D. F., and Engelhard, V. H. Cytotoxic T-lymphocyte response to autologous human squamous cell cancer of the lung: epitope reconstitution with peptides extracted from HLA-Aw68. Cancer Res., 54: 2731-2737, 1994.
25. Takenoyama, M., Yoshino, I., Fujie, H., Hanagiri, T., Yoshimatsu, T., Imabayashi, S., Eifuku, R., Nomoto, K., and Yasumoto, K. Autologous tumor-specific cytotoxic T lymphocytes in a patient with lung adenocarcinoma: implications of the shared antigens expressed in HLA-A24 lung cancer cells. Jpn. J. Cancer Res., 89: 60-66, 1998.
26. Weynants, P., Thonnard, J., Marchand, M., Delos, M., Boon, T., and Coulie, P. G. Derivation of tumor-specific cytolytic T-cell clones from two lung cancer patients with long survival. Am. J. Respir. Crit. Care Med., 159: 55-62, 1999.
27. Darrow, T. L., Slingluff, C. L., Jr., and Seigler, H. F. The role of HLA class I antigens in recognition of melanoma cells by tumor-specific cytotoxic T lymphocytes: evidence for shared tumor antigens. J. Immunol., 142: 3329-3335, 1989.
28. Crowley, N. J., Slingluff, C. L., Jr., Darrow, T. L., and Seigler, H. F. Generation of human autologous melanoma-specific cytotoxic T-cells using HLA-A2-matched allogeneic melanomas. Cancer Res., 50: 492-498, 1990.
29. Traversari, C., van der Bruggen, P., Luescher, I. F., Lurquin, C., Chomez, P., Van Pel, A., De Plaen, E., Amar-Costesec, A., and Boon, T. A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J. Exp. Med., 176: 1453-1457, 1992.
30. Celis, E., Fikes, J., Wentworth, P., Sidney, J., Southwood, S., Maewal, A., Del Guercio, M. F., Sette, A., and Livingston, B. Identification of potential CTL epitopes of tumor-associated antigen MAGE-1 for five common HLA-A alleles. Mol. Immunol., 31: 1423-1430, 1994.
31. Sidney, J., Grey, H. M., Kubo, R. T., and Sette, A. Practical, biochemical and evolutionary implications of the discovery of HLA class 1 supermotifs. Immunol. Today, 17: 261-266, 1996.
32. Huang, A. Y., Golumbek, P., Ahmadzadeh, M., Jaffee, E., Pardoll, D., and Levitsky, H. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science (Washington DC), 264: 961-965, 1994.
33. + T cell help. J. Exp. Med., 186: 65-70, 1997.
34. Ossendorp, F., Mengede, E., Camps, M., Filius, R., and Melief, C. J. M. Specific T helper cell requirement for optimal induction of cytolytic T lymphocytes against major histocompatibility complex class II negative tumors. J. Exp. Med., 187: 693-702, 1998.
35. Linsley, P. S., and Ledbetter, J. A. The role of the CD28 receptor during T cell responses to antigen. Annu. Rev. Immunol., 11: 191-212, 1993.
36. Bluestone, J. A. New perspectives of CD28-B7-mediated T cell costimulation. Immunity, 2: 555-559, 1995.
37. Bennett, S. R. M., Carbone, F. R., Karamalis, F., Flavell, R. A., Miller, J. F. A. P., and Heath, W. R. Help for cytotoxic-T cell responses is mediated by CD40 signalling. Nature (Lond.), 393: 478-480, 1998.
38. + T-cell responses. Immunol. Today, 17: 410-414, 1996.
39. + T-helper and a T-killer cell. Nature (Lond.), 393: 474-478, 1998.
40. Schoenberger, S. P., Toes, R. E. M., van der Voort, E. I. H., Offringa, R., and Melief, C. J. M. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature (Lond.), 393: 480-483, 1998.
41. Sotomayor, E. M., Borrello, I., and Levitsky, H. I. Tolerance and cancer: a critical issue in tumor immunology. Crit. Rev. Oncog., 7: 433-456, 1996.
42. + immunoregulalory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med., 188: 287-296, 1998.
43. Groux, H., O'Garra, A., Bigler, M., Rouleau, M., Antonenko, S., de Vries, J. E., and Roncarolo, M. G. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature (Lond.), 389: 737-742, 1997.
44. Savaraj, N., Wu, C. J., Xu, R., Lampidis, T., Lai, S., Donnelly, E., Solomon, J., and Feun, L. G. Multidrug-resistant gene expression in small-cell lung cancer. Am. J. Clin. Oncol., 20: 398-403, 1997.
45. Karasuyama, H., Kudo, A., and Melchers, F. The proteins encoded by the Vprep and λ5 pre-B cell-specific genes can associate with each other and μ heavy chain. J. Exp. Med., 172: 969-972, 1990.
46. Ohe, Y., Zhao, D., Saijo, N., and Podack, E. R. Construction of a novel bovine papillomavirus vector without detectable transforming activity suitable for gene transfer. Hum. Gene Ther., 6: 325-333, 1995.
47. Freeman, G. J., Freedman, A. S., Segil, J. M., Lee, G., Whitman, J. F., and Nadler, L. M. B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells. J. Immunol., 143: 2714-2722, 1989.
48. Karasuyama, H., and Melchers, F. Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors. Eur. J. Immunol., 18: 97-104, 1988.
49. Hartman, S. C., and Mulligan, R. C. Two dominant-acting selectable markers for gene transfer studies in mammalian cells. Proc. Natl. Acad. Sci. USA, 85: 8047-8051, 1988.
50. Nishio, M., and Podack, E. R. Rapid induction of tumor necrosis factor cytotoxicity in naive splenic T cells by simultaneous CD80 (B7.1) and CD54 (ICAM-1) costimulation. Eur. J. Immunol., 26: 2160-2164, 1996.
51. Terasaki, P. I., Bernoco, F., Park, M. S., Ozturk, G., and Iwaki, Y. Microdroplet testing for HLA A, B, C and D antigens. Am. J. CHn. Pathol., 69: 103-120, 1978.
52. Miltenyi, S., Muller, W., Weichel, W., and Radbruch, A. High gradient magnetic cell separation with MACS. Cytometry, 11: 231-238, 1990.
53. Lefkovits, I., and Waldmann, H. Limiting dilution analysis of the cells of immune system. I. The clonal basis of the immune response. Immunol. Today, 5: 265-268, 1984.
54. Mazzocchi, A., Belli, F., Mascheroni, L., Vegetti, C., Parmiani, G., and Anichini, A. Frequency of cytotoxic T lymphocyte precursors (CTLp) interacting with autologous tumor via the T-cell recepto: limiting dilution analysis of specific CTLp in peripheral blood and tumor-invaded lymph nodes of melanoma patients. Int. J. Cancer, 1994: 330-339, 1994.
55. Altmann, D. M., Hogg, N., Trowsdale, J., and Wilkinson, D. Cotransfection of ICAM-1 and HLA-DR reconstitutes human antigen-presenting cell function in mouse L cells. Nature (Lond.), 338: 512-514, 1989.
56. Coulie, P. G., Somville, M., Lehmann, F., Hainaut, P., Brasseur, F., Devos, R., and Boon, T. Precursor frequency analysis of human cytolytic T lymphocytes directed against autologous melanoma cells. Int. J. Cancer, 50: 289-297, 1992.
57. Weynants, P., Lethe, B., Brasseur, F., Marchand, M., and Boon, T. Expression of mage genes by non-small-cell lung carcinomas. Int. J. Cancer, 56: 826-829, 1994.
58. Pfizenmaier, K., Bartsch, H., Scheurich, P., Seliger, B., Ucer, U., Vehmeyer, K., and Nagel, G. A. Differential γ-interferon response of human colon carcinoma cells: inhibition of proliferation and modulation of immunogenicity as independent effects of γ-interferon on tumor cell growth. Cancer Res., 45: 3503-3509, 1985.